Gudrun Reiterer
Overview
Explore the profile of Gudrun Reiterer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reiterer G, Chen L, Tassef R, Varner J, Chen C, Yen A
Cell Cycle
. 2010 Aug;
9(16):3297-304.
PMID: 20703093
The role of JAK signaling in cell cycle transit and maintenance of genomic stability was determined in HL-60 human myeloblastic leukemia cells. We have previously reported that a pan-JAK inhibitor...
2.
Smith J, Bunaciu R, Reiterer G, Coder D, George T, Asaly M, et al.
Exp Cell Res
. 2009 Mar;
315(13):2241-8.
PMID: 19298812
All trans-retinoic acid (RA) is a standard therapeutic agent used in differentiation induction therapy treatment of acute promyelocytic leukemia (APL). RA and its metabolites use a diverse set of signal...
3.
Kauss M, Reiterer G, Bunaciu R, Yen A
Exp Cell Res
. 2008 Aug;
314(16):2999-3006.
PMID: 18692045
Estrogen receptors are historically perceived as nuclear ligand activated transcription factors. An estrogen receptor has now been found localized to the plasma membrane of human myeloblastic leukemia cells (HL-60). Its...
4.
Reiterer G, Bunaciu R, Smith J, Yen A
FEBS Lett
. 2008 Jun;
582(17):2508-14.
PMID: 18571505
PDGFR inhibitors are successfully used in a number of cancer treatments. The standard treatment for acute promyelocytic leukemia (APL) involves differentiation therapy with retinoic acid (RA). However, the relapse rates...
5.
Wang L, Reiterer G, Toborek M, Hennig B
Chem Biol Interact
. 2007 Dec;
172(1):27-38.
PMID: 18155686
Exposure to persistent organic pollutants, such as polychlorinated biphenyls (PCBs) can cause endothelial cell (EC) activation by inducing pro-inflammatory signaling pathways. Our previous studies indicated that linoleic acid (LA, 18:2),...
6.
Arzuaga X, Reiterer G, Majkova Z, Kilgore M, Toborek M, Hennig B
Cardiovasc Toxicol
. 2007 Oct;
7(4):264-72.
PMID: 17955387
Exposure to polychlorinated biphenyls (PCBs) can activate inflammatory responses in vascular endothelial cells. Activation of peroxisome proliferator-activated receptors (PPARs) by nutrients or synthetic agonists has been shown to block pro-inflammatory...
7.
Reiterer G, Yen A
Cancer Res
. 2007 Aug;
67(16):7765-72.
PMID: 17699781
Here, we show that the platelet-derived growth factor receptor (PDGFR) regulates myeloid and monocytic differentiation of HL-60 myeloblastic leukemia cells in response to retinoic acid (RA) and vitamin D3 (D3),...
8.
Reiterer G, Yen A
Cancer Res
. 2006 Sep;
66(18):9083-9.
PMID: 16982750
The role of Janus-activated kinase (JAK) signaling in cell cycle transit and maintenance of genomic stability was determined in HL-60 myeloblastic leukemia cells. Inhibition of JAKs, all JAKs (JAK1, JAK2,...
9.
Reiterer G, Macdonald R, Browning J, Morrow J, Matveev S, Daugherty A, et al.
J Nutr
. 2005 Sep;
135(9):2114-8.
PMID: 16140885
Low zinc concentration can be associated with an increased risk of cardiovascular diseases. In the current study, we hypothesize that zinc deficiency can increase and zinc supplementation can decrease proatherosclerotic...
10.
Hennig B, Reiterer G, Majkova Z, Oesterling E, Meerarani P, Toborek M
Cardiovasc Toxicol
. 2005 Jul;
5(2):153-60.
PMID: 16046791
We hypothesize that nutrition can modulate the toxicity of environmental pollutants and thus modulate health and disease outcome associated with chemical insult. There is now increasing evidence that exposure to...